SCHEMBL23925779

SCHEMBL23925779

O=C1Cc2c(-c3ccccc3)cc(-c3ccccc3)c(C(=O)c3ccccc3)c2O1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.40
L3MBTL1 Q9Y468 3/20 0.40
POLB P06746 1/20 0.40
ALDH1A1 P00352 7/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
MAPT P10636 3/20 0.39
NPC1 O15118 2/20 0.39
PKM P14618 1/20 0.39
HPGD P15428 1/20 0.39
RAB9A P51151 1/20 0.39
NPSR1 Q6W5P4 3/20 0.36
LMNA P02545 2/20 0.36
XBP1 P17861 1/20 0.36
HKDC1 Q2TB90 1/20 0.36
MAOA P21397 1/20 0.36
MAOB P27338 1/20 0.36
CYP2C8 P10632 1/20 0.36
CYP2C9 P11712 1/20 0.36
PDE4A P27815 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1667165 0.64 ALDH1A1 (0.56) SMN1; SMN2L3MBTL1POLBALDH1A1MEN1
SCHEMBL7696381 0.64 ALDH1A1 (0.56) SMN1; SMN2L3MBTL1ALDH1A1MEN1KMT2A
SCHEMBL23940770 0.63 AKR1B1 (0.51) MAOAMAOB
SCHEMBL5491735 0.63 ALDH1A1 (0.63) SMN1; SMN2L3MBTL1POLBALDH1A1MEN1
SCHEMBL671399 0.62 GRM6 (0.46) SMN1; SMN2L3MBTL1POLBALDH1A1MEN1
SCHEMBL8164412 0.62 GRM6 (0.46) SMN1; SMN2L3MBTL1POLBALDH1A1MEN1
SCHEMBL23925731 0.62 KDM4E (0.37) SMN1; SMN2ALDH1A1MAPTHPGDMAOB
SCHEMBL5959807 0.61 CYP2C9 (0.58) ALDH1A1MEN1KMT2AMAPTRAB9A
Benzophenone SCHEMBL8777480 0.61 AKR1C3 (0.52) L3MBTL1POLBALDH1A1CYP2C8CYP2C9
Benzophenone SCHEMBL260937 0.61 ALDH1A1 (0.82) SMN1; SMN2L3MBTL1POLBALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230117370-A1 REGIOSELECTIVE SYNTHESIS OF SUBSTITUTED COMPOUNDS OREGON STATE UNIVERSITY (US) 2023-04-20 US claimed
WO-2021211982-A2 REGIOSELECTIVE SYNTHESIS OF SUBSTITUTED COMPOUNDS OREGON STATE UNIVERSITY (US) 2021-10-21 WO claimed
US-20230117370-A1 REGIOSELECTIVE SYNTHESIS OF SUBSTITUTED COMPOUNDS OREGON STATE UNIVERSITY (US) 2023-04-20 US disclosed
WO-2021211982-A2 REGIOSELECTIVE SYNTHESIS OF SUBSTITUTED COMPOUNDS OREGON STATE UNIVERSITY (US) 2021-10-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230117370-A1 REGIOSELECTIVE SYNTHESIS OF SUBSTITUTED COMPOUNDS CYP2B6, TYR, CYP2D6 SMN1; SMN2 4360/4885L3MBTL1 4715/4885POLB 2049/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.